Risperidone in the treatment of schizophrenia.: A therapy study.

被引：0
|
作者：
Stuppäck, CH [1 ]
机构：
[1] Landesnervenklin Salzburg, Psychiat Abt 1, A-5020 Salzburg, Austria
来源：
NEUROPSYCHIATRIE | 1999年 / 13卷 / 01期
关键词：
risperidone; schizophrenia; therapy study;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
260 in- and outpatients suffering from schizophrenia were included in a therapy study with Risperidone. The mean daily dose amounted to 3.9 mg. The mean treatment periode was 104 days (s.d. +/- 61). Patients showed a statistically significant decrease in the rating scales used (CGI, BPRS, PANSS). Risperidone was very well tolerated, only 4.2% of the patients had to be withdrawn due to side effects. Another important result of the study presented is, that extrapyramidal motoric symptoms decreased significantly during the treatment with Risperidone. Rispsridone proved to be effective in schizophrenic patients against positive as well as negative symptoms and showed a favourable side effect profile.
引用
收藏
页码：18 / 22
页数：5
相关论文
共 50 条
  • [1] Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
    Garcia-Cabeza, Ignacio
    Gomez, Juan-Carlos
    Sacristan, Jose A.
    Edgell, Eric
    Gonzalez de Chavez, Manuel
    BMC PSYCHIATRY, 2001, 1 (1)
  • [2] Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
    Ignacio García-Cabeza
    Juan-Carlos Gómez
    Jose A Sacristán
    Eric Edgell
    Manuel González de Chavez
    BMC Psychiatry, 1
  • [3] Treatment-refractory schizophrenia.
    Buckley P.F.
    Wiggins L.D.
    Sebastian S.
    Singer B.
    Current Psychiatry Reports, 2001, 3 (5) : 393 - 400
  • [4] Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia
    Conley, RR
    Kelly, DL
    Nelson, MW
    Richardson, CM
    Feldman, S
    Benham, R
    Steiner, P
    Khan, I
    McMullen, R
    Gale, E
    Mackowick, M
    Love, RC
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (04) : 163 - 168
  • [5] Antipsychotic treatment for late-life schizophrenia.
    Sable J.A.
    Jeste D.V.
    Current Psychiatry Reports, 2002, 4 (4) : 299 - 306
  • [6] Risperidone versus olanzapine for treatment of schizophrenia
    Jayaram, Mahesh B.
    Hosalli, Prakash M.
    Stroup, Thomas S.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (06) : 1274 - 1276
  • [7] Pharmacotherapy Update: Risperidone in the Treatment of Schizophrenia
    Raja, Michele
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1199 - 1214
  • [8] Treatment of Cognitive Impairment in Schizophrenia.
    Vita, A.
    EUROPEAN PSYCHIATRY, 2022, 65 : S48 - S49
  • [9] Analysis of diffusion parameters in the cst of patients with early stage of schizophrenia. dti study.
    Ublinskiy, M.
    Semenova, N.
    Akhadov, T.
    Manzhurtsev, A.
    Yakovlev, A.
    EUROPEAN PSYCHIATRY, 2020, 63 : S542 - S542
  • [10] Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study
    Bo, Qijing
    Li, Feng
    Li, Xianbin
    Wang, Zhimin
    Dong, Fang
    He, Fan
    Li, Anning
    Ma, Xin
    Wang, Chuanyue
    PSYCHIATRY RESEARCH, 2017, 258 : 289 - 294
12345